# Healthtech
The latest news and analysis on Europe’s healthtech startups, including healthcare innovation, digital health, femtech, pharma and medtech.
- 14 Italian early stage startups to watch, according to VCs
14 Italian early stage startups to watch, according to VCs
- Stryker to invest $400m in CMR Surgical, with option to buy it outrightNews
October 12, 2026
Stryker to invest $400m in CMR Surgical, with option to buy it outright
- Exclusive: Weight loss startup Yazen raises €50m led by VerdaneExclusive
October 8, 2026
Exclusive: Weight loss startup Yazen raises €50m led by Verdane
- Owkin alum raises $25m seed to build world model for human cells
Owkin alum raises $25m seed to build world model for human cells
- Voice AI startup Vocca raises $20m to automate patient phone callsNews
October 6, 2026
Voice AI startup Vocca raises $20m to automate patient phone calls
- ‘Pushing the frontier is best done outside’: DeepMind alum Simon Kohl on leaving Big Tech
‘Pushing the frontier is best done outside’: DeepMind alum Simon Kohl on leaving Big Tech
- Exclusive: Vsquared and East X Ventures lead £10m seed for rare materials startup
Exclusive: Vsquared and East X Ventures lead £10m seed for rare materials startup
- Exclusive: Femtech Ipremom raises €15m seed for early detection of pregnancy complications
Exclusive: Femtech Ipremom raises €15m seed for early detection of pregnancy complications
- ‘I’m not here to be acquired’: Meet Nabla’s new CEO Brian Manning
‘I’m not here to be acquired’: Meet Nabla’s new CEO Brian Manning
- 13 technical founders across Europe to watch, according to VCs
13 technical founders across Europe to watch, according to VCs
- Neko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’
Neko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’
- Why late-stage secondary offerings are transforming private market accessPaid for and produced by
July 14, 2026
Why late-stage secondary offerings are transforming private market access
- Tandem Health CEO: ‘We’re not dependent on OpenAI or Anthropic’
Tandem Health CEO: ‘We’re not dependent on OpenAI or Anthropic’
- All female-GP firm Thena Capital raises £45m for debut healthcare fund
All female-GP firm Thena Capital raises £45m for debut healthcare fund
- How bio:cap is reconnecting Europe’s life sciences ecosystemSponsored by
June 4, 2026
How bio:cap is reconnecting Europe’s life sciences ecosystem
- Exclusive: General Catalyst backs YC alum Lucis in $20m Series A
Exclusive: General Catalyst backs YC alum Lucis in $20m Series A